PRIMARY SURGICAL THERAPY FOR BIOLOGICALLY DEFINED LOW-RISK NEUROBLASTOMA

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。这项研究不对新入学学生开放。(来自国家癌症研究所的PDQ数据库的临床试验摘要)单独手术可能对患有神经母细胞瘤的儿童有效。这是一项第三阶段试验，研究单独手术治疗儿童神经母细胞瘤的有效性。患者将接受手术切除肿瘤和受影响的淋巴结。一些患者还可能接受联合化疗、进一步手术和/或放射治疗。患者将接受后续评估

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is closed to new enrollment. (Clinical trial summary from the National Cancer Institute's PDQ database) Surgery alone may be effective in treating children with neuroblastoma.This is a Phase III trial to study the effectiveness of surgery alone in treating children who have neuroblastoma. Patients will undergo surgery to remove the tumor and involved lymph nodes. Some patients may also receive combination chemotherapy, further surgery, and/or radiation therapy. Patients will receive follow-up evaluation